infants in whom necrotizing enterocolitis develops. Arch Surg 1980;115: 1050. 13. Garite TJ. Premature rupture of membranes, the enigma of the obstetrician. Am J Obstet Gynecol 1985;151:1001-5. 14. Chen A, Feresu S, Barsoom MJ. Heterogeneity of preterm birth subtypes in relation to neonatal death. Obstet Gynecol 2009;114: 516-22. 15. Newman DE, Paamoni-Keren O, Press F, et al. Neonatal outcome in preterm deliveries between 23 and 27 weeks’ gestation with and without preterm premature rupture of membranes. Arch Gynecol Obstet 2009;280:6-11. 16. Kamath-Rayne BD, DeFranco EA, Chung E, Chen A. Subtypes of preterm birth and risk of postneonatal death. J Pediatr 2013;162:28-34. 17. Combs CA, Gravett M, Garite TJ, et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014;210:125. 18. Romero R, Yoon BH, Mazor M, et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;16:805-16. 19. ACOG Practice Bulletin: Premature rupture of membranes. Obstet Gynecol 2016;160:128. 165-77. 20. Kacerovsky M, Musilova I, Andrys C. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am Obstet Gynecol 2014;210:325-42. 21. Cobo T, Palacio M, Martínez-Terrón M, Nava A. Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. Am J Obset Gynecol 2011;205:126-32. 22. Higgins RD, Saade G, Polin RA, et al. Chorioamnionitis Workshop Participants. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol 2016;127: 426-36. 23. Ramsey PS, Lieman JM, Brumfield CG, Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol 2005;192:1162-6. 24. Garite TJ, Clark RH, Thorp JA. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol 2004;191:481-7. 25. Escobar GJ, Clark RH, Greene JD. Shortterm outcomes of infants born at 35 and 36 weeks gestation: we need to ask more questions. Semin Perinatol 2006;30:28-33. 26. Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the national institute of child health and human development. Pediatrics 2006;118:1207-14. 27. Laughon MM, Avant D, Tripathi N, et al. Drug labeling and exposure in neonates. JAMA Pediatr 2014;168:130-6. 28. Becker KC, Hornik CP, Cotten CM, et al. Necrotizing enterocolitis in infants with ductaldependent congenital heart disease. Am J Perinatol 2015;32:633-8. 29. Chu PY, Hill KD, Clark RH, Smith PB, Hornik CP. Treatment of supraventricular tachycardia in infants: analysis of a large multicenter database. Early Hum Dev 2015;91: 345-50. 30. Committee opinion no. 611: method for estimating due date. Obstet Gynecol 2014;124: 863-6. 31. Bell MJ, Ternberg H, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on staging criteria. Ann Surg 1978;187:1. 32. Garite TJ, Kurtzman J, Maurel K, Clark R; Obstetrix Collaborative Research Network. Impact of a rescue course’ of antenatal corticosteroids: a multicenter randomized ajog.org OBSTETRICS Original Research JULY 2017 American Journal of Obstetrics & Gynecology 72.e8 placebo-controlled trial. Am J Obstet Gynecol 2009;200:248.e1-9. 33. Garite TJ, Freeman RK. Chorioamnionitis inthe preterm gestation. Obstet Gynecol 1982;59: 539-45. 34. Delorme P, Goffinet F, Ancel P-Y, et al. Cause of preterm birth as a prognostic factor for mortality. Obstet Gynecol 2016;127:40-8. 35. Gagliardi L, Rusconi F, Da Fre M, et al. Pregnancy disorders leading to very preterm birth influence neonatal outcomes: results from the population based ACTION cohort study. Pediatr Res 2013;73:794-801. Author and article information From the University of California, Irvine Medical Center, Orange, CA (Dr Garite); Obstetrix Medical Group, Center for Research Education & Quality, Mednax, Inc., Sunrise, FL (Drs Garite, Combs, Ms Maurel, and Obstetrix Collaborative Research Network); Obstetrix Medical Group, California, San Jose, CA (Dr Combs); Das Consulting, San Francisco, CA (Dr Das); Phoenix Perinatal Associates/Mednax Inc., Phoenix, AZ (Dr Huls); Obstetrix Medical Group, Denver, CO (Dr Porreco); Obstetrix Medical Group, Seattle, WA (Dr Reisner); Obstetrix Medical Group, Kansas City, MO (Dr Lu); Obstetrix Medical Group, Southern California, Laguna Hills, CA (Dr Bush); Midwest Maternal-Fetal Medicine, St. Louis, MO (Dr Morris); and Obstetrix Medical Group of Texas, Fort Worth, TX (Dr Blei Leaders in High-Risk Obstetrics, Fetal Care & Newborn Management 1 NewYork-Presbyterian/Columbia University Medical Center is one of the nation’s most comprehensive and technologically advanced academic medical centers, with leading specialists in both adult and pediatric care. One of a handful of regional referral centers for pregnancies that may be at risk for a premature or complicated delivery